Cabergol is used to stop breast milk production (lactation) soon after childbirth, stillbirth, abortion or miscarriage. It can also be used if do not want to continue to breastfeed.Cabergol can also be used to treat other conditions caused by hormonal disturbance which can result in high levels of prolactin being produced. This includes high levels of prolactin caused by tumours of the pituitary gland in both men and women.
Dosage & Administration
The recommended dosage of Cabergol Tablets for initiation of therapy is 0.25 mg twice a week. Dosage may be increased by 0.25 mg twice weekly up to a dosage of 1 mg twice a week according to the patient's serum prolactin level. Dosage increases should not occur more rapidly than every 4 weeks, so that the physician can assess the patient's response to each dosage level. If the patient does not respond adequately and no additional benefit is observed with higher doses, the lowest dose that achieved maximal response should be used and other therapeutic approaches considered. After a normal serum prolactin level has been maintained for 6 months, Cabergol may be discontinued, with periodic monitoring of the serum prolactin level to determine whether or when treatment with Cabergol should be reinstituted.
- To prevent milk production (lactation): 1mg (two 0.5 mg tablets) on the first day after delivery.
- To stop lactation once have started to breastfeed: 0.25 mg (one half of Cabergol 0.5 mg tablet) every 12 hours for two days.
- To reduce prolactin levels in other conditions: Initially take one 0.5 mg tablet (to be taken in two doses) spread out over a week (e.g. half a tablet on Monday and the other half of the tablet on Thursday). Dose will be increased up to a maximum dose of 4.5 mg or until have responded fully to treatment
- Hypersensitive (allergic) to Cabergol, to other medicines called ergot alkaloids, (e.g. pergolide, bromocriptine, lisuride, ergotamine or ergometrine) or to any of the other ingredients in the tablet
- Severe liver disease
- High blood pressure in pregnancy associated with swelling and protein in the urine (toxaemia of pregnancy)
- Anti-psychotics or have a history of mental illness associated with child-birth (puerperal psychosis)
- Pregnant or breastfeeding
- Treated with Cabergol for a long period and have or had fibrotic reactions (scar tissue) affecting your heart
Use In Pregnancy & Lactation
Pregnant or planning to get pregnant, discuss this with doctor before treatment though the pregnancy category B. Before start using Cabergol check that patient not pregnant. Pregnant for at least one month once have stopped taking Cabergol, As Cabergol will stop producing milk.If someone plan to breastfeed should not take Cabergol.